Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to $237000.0.

  • Champions Oncology's Consolidated Net Income fell 6744.51% to $237000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $2.4 million, marking a year-over-year increase of 50652.17%. This contributed to the annual value of $4.7 million for FY2025, which is 16460.97% up from last year.
  • According to the latest figures from Q4 2025, Champions Oncology's Consolidated Net Income is $237000.0, which was down 6744.51% from -$466000.0 recorded in Q3 2025.
  • In the past 5 years, Champions Oncology's Consolidated Net Income ranged from a high of $4.5 million in Q1 2025 and a low of -$2.6 million during Q3 2023
  • Moreover, its 5-year median value for Consolidated Net Income was -$245500.0 (2021), whereas its average is -$365250.0.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first skyrocketed by 2760000.0% in 2021, then tumbled by 1284375.0% in 2023.
  • Quarter analysis of 5 years shows Champions Oncology's Consolidated Net Income stood at $277000.0 in 2021, then tumbled by 105.78% to -$16000.0 in 2022, then plummeted by 12843.75% to -$2.1 million in 2023, then skyrocketed by 135.15% to $728000.0 in 2024, then tumbled by 67.45% to $237000.0 in 2025.
  • Its last three reported values are $237000.0 in Q4 2025, -$466000.0 for Q3 2025, and -$1.8 million during Q2 2025.